Benchmark Corp. brings Hunters’ leading open XDR platform to Canadian market Benchmark Corp. brings Hunters’ leading open XDR platform to Canadian market
NEWTON, Mass. and TEL AVIV, Israel, March 02, 2021 (GLOBE NEWSWIRE) — Hunters today announced…
Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020
Company announcement – No. 9 / 2021 Zealand Pharma Hosts Conference Call on March 11…
Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy
Pratteln, Switzerland, March 3, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that the last patient has…
MDxHealth Reports Financial Year 2020 Results and Provides Outlook for 2021
NEWS RELEASE – REGULATED INFORMATION 3 MARCH 2021, 07:00 A.M. CET Conference call with Q&A today…
ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference
Geneva, Switzerland and Boston, MA – March 3, 2021 – ObsEva SA (NASDAQ: OBSV /…
Idorsia submits European marketing authorisation application for daridorexant for the treatment of adult patients with insomnia
• The application includes robust data from the Phase 3 registration program, which demonstrated efficacy…
In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit
In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit In…
ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares
SINGAPORE, March 03, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused…
Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical…
Rezolute to Participate in Upcoming Investor Conferences in March
REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), today announced…